|
Volumn 17, Issue 11, 2009, Pages 847-851
|
Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
18ALPHA,20BETA HYDROXY 11 OXO NOROLEAN 12 EN 3BETA YL 2 O BETA D GLUCOPYRANUROSYL ALPHA D GLUCOPYRANOSIDURONATE MAGNESIUM TETRAHYDRATE;
18ALPHA,20BETA-HYDROXY-11-OXO-NOROLEAN-12-EN-3BETA-YL-2-O-BETA-D-GLUCOPYRANUROSYL-ALPHA-D-GLUCOPYRANOSIDURONATE MAGNESIUM TETRAHYDRATE;
ALANINE AMINOTRANSFERASE;
ANTIINFLAMMATORY AGENT;
ASPARTATE AMINOTRANSFERASE;
GLYCYRRHIZIC ACID;
SAPONIN;
TRITERPENE;
ALCOHOL LIVER DISEASE;
ARTICLE;
BLOOD;
CHRONIC DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FATTY LIVER;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER;
LIVER DISEASE;
MALE;
MULTICENTER STUDY;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ALANINE TRANSAMINASE;
ANTI-INFLAMMATORY AGENTS;
ASPARTATE AMINOTRANSFERASES;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
FATTY LIVER;
FEMALE;
GLYCYRRHIZIC ACID;
HUMANS;
INJECTIONS, INTRAVENOUS;
LIVER;
LIVER DISEASES;
LIVER DISEASES, ALCOHOLIC;
MALE;
SAPONINS;
TRITERPENES;
|
EID: 77956194846
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (32)
|
References (0)
|